Question # 6

A 66-year-old patient with a history of hypertension, dyslipidemia, and a recent non-cardioembolic ischemic stroke is evaluated for secondary prevention discharge medications. According to current guidelines, which of the following antiplatelet regimens is standard for long-term secondary prevention in non-cardioembolic stroke?

Options:

A.

Monotherapy with aspirin (81-325 mg daily), clopidogrel (75 mg daily), or extended-release dipyridamole/aspirin.

B.

Lifelong continuous intravenous heparin infusion adjusted according to partial thromboplastin time.

C.

Warfarin therapy with a target international normalized ratio (INR) of 4.0 to 5.0 indefinitely.

D.

High-dose oral non-steroidal anti-inflammatory drugs (NSAIDs) administered daily.

Viewing question 6 out of 47 questions
Industry research shows that students who utilize SCRN practice tests are significantly more likely to pass exam.


Our free SCRN practice questions act as a diagnostic tool to give you a clear snapshot of your Stroke Certified Registered Nurse (SCRN) Examination readiness. Discover which topics are your strengths and, more importantly, which critical topics require your immediate attention.